Category: NSV News

New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million

New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million

New York (NY, US), London (UK), March 9th, 2021 – New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, announces that its portfolio company Ventyx Biosciences raised $114 million from blue-chip investors to advance a diverse pipeline

Read More
New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence

New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence

New York (NY, US), London (UK), January 12, 2021 – New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, today announces the merger of its portfolio company, Achronix Semiconductor Corporation (“Achronix”), with ACE Convergence Acquisition Corp. NSV

Read More